Publications by authors named "Marco Pizzoferrato"

Claim this Profile
C
Clinical Predictive Factors for the Development of Short Bowel Syndrome in a Cohort of Patients with Crohn's Disease: A Prospective Study.
Laura Parisio, Angelo Del Gaudio, Jacopo Iaccarino, Pierluigi Puca, Guia Becherucci, Marco Pizzoferrato

J Clin Med· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Intestinal-Failure-Associated Liver Disease: Beyond Parenteral Nutrition.
Irene Mignini, Giulia Piccirilli, Federica Di Vincenzo, Carlo Covello, Marco Pizzoferrato

Biomolecules· March 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Parenteral Nutrition, Inflammatory Bowel Disease, and Gut Barrier: An Intricate Plot.
Carlo Covello, Guia Becherucci, Federica Di Vincenzo, Angelo Del Gaudio, Marco Pizzoferrato

Nutrients· July 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Micro(nano)plastics and Their Potential Impact on Human Gut Health: A Narrative Review.
Carlo Covello, Federica Di Vincenzo, Giovanni Cammarota, Marco Pizzoferrato

Curr Issues Mol Biol· March 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Henoch-schonlein purpura following exposure to SARS-CoV2 vaccine or infection: a systematic review and a case report.
Federica Di Vincenzo, Sara Ennas, Marco Pizzoferrato, Stefano Bibbò, Serena Porcari

Intern Emerg Med· January 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effectiveness and Safety of Switching from Intravenous to Subcutaneous Vedolizumab Formulation in Inflammatory Bowel Disease Patients in Clinical Remission.
Laura Parisio, Carlo Romano Settanni, Simone Varca, Lucrezia Laterza, Loris Riccardo Lopetuso, Marco Pizzoferrato

J Gastrointestin Liver Dis· December 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Glucagon-like peptide-2 analogues for Crohn's disease patients with short bowel syndrome and intestinal failure.
Marco Pizzoferrato, Pierluigi Puca, Sara Ennas, Giovanni Cammarota, Luisa Guidi

World J Gastroenterol· November 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Intestinal Permeability and Dysbiosis in Female Patients with Recurrent Cystitis: A Pilot Study.
Cristina Graziani, Lucrezia Laterza, Claudia Talocco, Marco Pizzoferrato, Nicoletta Di Simone

J Pers Med· June 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Risk Factors, Diagnosis, and Management of Infection in Patients with Inflammatory Bowel Disease.
Livio Enrico Del Vecchio, Marcello Fiorani, Ege Tohumcu, Stefano Bibbò, Serena Porcari, Marco Pizzoferrato

Microorganisms· June 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Impact of SARS-CoV-2 Infection on the Course of Inflammatory Bowel Disease in Patients Treated with Biological Therapeutic Agents: A Case-Control Study.
Alfredo Papa, Franco Scaldaferri, Marcello Covino, Antonio Tursi, Federica Furfaro, Marco Pizzoferrato

Biomedicines· April 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comparison of performances of infliximab biosimilars CT-P13 versus SB2 in the treatment of inflammatory bowel diseases: a real-life multicenter, observational study in Italy.
Antonio Tursi, Giammarco Mocci, Leonardo Allegretta, Giovanni Aragona, Maria Antonia Bianco, Marco Pizzoferrato

Expert Opin Biol Ther· February 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Impact of COVID-19 pandemic on the daily management of biotechnological therapy in inflammatory bowel disease patients: Reorganisational response in a high-volume Italian inflammatory bowel disease centre.
Franco Scaldaferri, Daniela Pugliese, Giuseppe Privitera, Sara Onali, Loris Riccardo Lopetuso, Marco Pizzoferrato

United European Gastroenterol J· August 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Nutrition, IBD and Gut Microbiota: A Review.
Maria Chiara Mentella, Franco Scaldaferri, Marco Pizzoferrato, Antonio Gasbarrini, Giacinto Abele Donato Miggiano

Nutrients· March 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Acute intramucosal dissection in eosinophilic esophagitis.
Francesca Fianchi, Giuseppe De Matteis, Rossella Cianci, Marco Pizzoferrato, Silvia Cardone

Clin J Gastroenterol· December 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The Association of Disease Activity, BMI and Phase Angle with Vitamin D Deficiency in Patients with IBD.
Maria Chiara Mentella, Franco Scaldaferri, Marco Pizzoferrato, Antonio Gasbarrini, Giacinto Abele Donato Miggiano

Nutrients· October 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Characterization of Sarcopenia in an IBD Population Attending an Italian Gastroenterology Tertiary Center.
Marco Pizzoferrato, Roberto de Sire, Fabio Ingravalle, Maria Chiara Mentella, Valentina Petito

Nutrients· September 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Skeletal muscle-gut axis: emerging mechanisms of sarcopenia for intestinal and extra intestinal diseases.
Roberto de Sire, Gianenrico Rizzatti, Fabio Ingravalle, Marco Pizzoferrato, Valentina Petito

Minerva Gastroenterol Dietol· December 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Gut microbiota and inflammatory bowel disease: so far so gut!
Grainne Holleran, Loris R Lopetuso, Gianluca Ianiro, Silvia Pecere, Marco Pizzoferrato

Minerva Gastroenterol Dietol· December 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Role and mechanisms of action of Escherichia coli Nissle 1917 in the maintenance of remission in ulcerative colitis patients: An update.
Franco Scaldaferri, Viviana Gerardi, Francesca Mangiola, Loris Riccardo Lopetuso, Marco Pizzoferrato

World J Gastroenterol· June 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Use and indications of cholestyramine and bile acid sequestrants.
Franco Scaldaferri, Marco Pizzoferrato, Francesca Romana Ponziani, Giovanni Gasbarrini, Antonio Gasbarrini

Intern Emerg Med· April 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Gastric non-secreting neuroendocrine tumor and hypochlorhydria-related hypergastrinemia: a case report.
Marco Biolato, Sergio Alfieri, Gianluca Ianiro, Marco Pizzoferrato, Giovanni Gasbarrini

J Med Case Rep· February 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The gut barrier: new acquisitions and therapeutic approaches.
Franco Scaldaferri, Marco Pizzoferrato, Viviana Gerardi, Loris Lopetuso, Antonio Gasbarrini

J Clin Gastroenterol· October 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Bacterial flora as a cause or treatment of chronic diarrhea.
Franco Scaldaferri, Marco Pizzoferrato, Silvia Pecere, Fabrizio Forte, Antonio Gasbarrini

Gastroenterol Clin North Am· September 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Propionyl-L-carnitine hydrochloride for treatment of mild to moderate colonic inflammatory bowel diseases.
Giuseppe Merra, Giovanni Gasbarrini, Lucrezia Laterza, Marco Pizzoferrato, Andrea Poscia

World J Gastroenterol· September 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Haemostatic system in inflammatory bowel diseases: new players in gut inflammation.
Franco Scaldaferri, Stefano Lancellotti, Marco Pizzoferrato, Raimondo De Cristofaro

World J Gastroenterol· February 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis